The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and epidemiologic investigations addressing the roles of co-infection and cancer to shed light on presently unestablished pathways in carcinogenesis that may inform prevention and treatment strategies for infection-related cancers. Co-infection is defined as the occurrence of infections by two or more infectious (pathogenic or non-pathogenic) agents either concurrently or sequentially and includes both acute and chronic infections by viruses, bacteria, parasites, and/or other microorganisms. Preference will be given to investigations of co-infections with known oncogenic agents (excluding human immunodeficiency virus [HIV]) and of co-infections that engender novel opportunities for prevention and treatment.
- HIV/AIDS
- Other Health-Related
- International
- Clinical Research
- Coinfections
- Data Analysis
- HIV
- HIV and AIDS Prevention
- Medical Treatments and Therapies
- Research
- City Agencies
- Colleges/Universities
- Commercial Organizations
- Community Based Organizations
- County Agencies
- Educational Organizations/Institutions
- Federal Government Agencies
- International Agencies
- IRS 501 (c)(3) Organizations
- Nonprofit Organizations
- Public Health Departments/Social Services Departments
- Religious Organizations
- Research Institutions
- State Agencies
- Tribal Organizations